FRM
BPMC
Fox Run Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,445
| Closed | -$1.01M | – | 883 |
|
|
2025
Q1 | $1.01M | Buy |
11,445
+1,181
| +12% | +$105K | 0.16% | 204 |
|
|
2024
Q4 | $895K | Buy |
10,264
+7,434
| +263% | +$648K | 0.16% | 202 |
|
|
2024
Q3 | $262K | Buy |
+2,830
| New | +$262K | 0.06% | 594 |
|
|
2024
Q2 | – | Sell |
-4,655
| Closed | -$442K | – | 789 |
|
|
2024
Q1 | $442K | Buy |
4,655
+2,152
| +86% | +$204K | 0.1% | 418 |
|
|
2023
Q4 | $231K | Buy |
+2,503
| New | +$231K | 0.06% | 592 |
|
|
2023
Q2 | – | Sell |
-5,300
| Closed | -$238K | – | 702 |
|
|
2023
Q1 | $238K | Buy |
+5,300
| New | +$238K | 0.08% | 470 |
|
|
2022
Q3 | – | Sell |
-6,082
| Closed | -$307K | – | 617 |
|
|
2022
Q2 | $307K | Buy |
+6,082
| New | +$307K | 0.15% | 288 |
|
|
2022
Q1 | – | Sell |
-2,228
| Closed | -$239K | – | 508 |
|
|
2021
Q4 | $239K | Buy |
+2,228
| New | +$239K | 0.14% | 305 |
|
|
2019
Q3 | – | Sell |
-3,550
| Closed | -$335K | – | 375 |
|
|
2019
Q2 | $335K | Buy |
+3,550
| New | +$335K | 0.22% | 185 |
|
|
2018
Q1 | – | Sell |
-11,067
| Closed | -$835K | – | 724 |
|
|
2017
Q4 | $835K | Buy |
+11,067
| New | +$835K | 0.24% | 102 |
|